The nightmare of FDA clearance/approval to market: perception or reality?

Issue title: BioTechnology in Dental Medicine

Article type: Research Article

Authors: Tylenda, Carolyn A.

Affiliations: Division of Dental Infection Control and General Hospital Devices, US Food and Drug Administration, HFZ-480, 9200 Corporate Blvd., Rockville, MD 20895, USA

Abstract: Over the last few years the Center for Device Evaluation and Research (CDRH) at the Food and Drug Administration (FDA) has received annually over 16 thousand submissions related to medical devices. Over 10,000 of these are major submissions which include applications to conduct clinical trials and applications to market medical devices for a specified indication for use. Each application is carefully considered. FDA personnel work closely with applicants to ensure that clinical trial design minimizes risk to the patients and maximizes benefit with respect to addressing the safety and effectiveness of the device being tested. Applicants are given every opportunity to provide additional information when necessary to assure that applications to market medical devices are complete. Applicants have the opportunity to meet with FDA staff prior to submitting applications in cases where the application is other than a straight forward, uncomplicated submission. In addition, FDA assists applicants through the development of guidance documents, which discuss the type of information that would be beneficial to include in a submission. The Division of Small Manufacturers Assistance at FDA is dedicated to helping interested persons understand the clearance/approval process. This paper will discuss the role of FDA in the regulation of medical devices, with an emphasis on the pathway to obtraining permission to market medical devices in the United States.

DOI: 10.3233/THC-1996-4304

Journal: Technology and Health Care, vol. 4, no. 3, pp. 259-267, 1996